Vimarsana
Biggest News Aggregation in the World

Page 2 - Pfizer Limited News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pfizer Limited. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pfizer Limited Today - Breaking & Trending Today

Pfizer Limited Announces Resignation of Samir Kazi as Director from the Board of Directors - Vimarsana News

Pfizer Limited Announces Resignation of Samir Kazi as Director from the Board of Directors

Pfizer Limited announced that Mr. Samir Kazi has resigned as a Director from the Board of Directors of the Company effective close of business September 12, 2023. to pursue an opportunity outside...

Pfizer Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 - Vimarsana News

Pfizer Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023

Pfizer Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 5,752.1 million compared to INR...

Related Topics:
Pfizer Limited
pharma stocks to buy: Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28% - Vimarsana News

pharma stocks to buy: Tactical buys in time of correction? 4 MNC pharma stocks with upside potential of up to 28%

In the last two decades MNC pharma companies, whose parent companies were setting up 100 percent owned subsidiaries in India and started routing their business through them, they all lost their shine on the market and have still not got it back. But sometimes these stocks tend to fall less in volatile markets, does this make them a tactical buy? We take a look at 4 MNC pharma companies where analysts have a Buy and Hold recommendation.

stocks: Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28% - Vimarsana News

stocks: Will they make a comeback? 4 MNC pharma stocks with upside potential of up to 28%

After the IT bull of 2000, as a new set of Indian companies took the centerstage, a number of MNCs stocks lost their shine at least on the street. Will they ever again get the tag of “ a must have” in one's portfolio ?. We take a look at 4 MNC pharma companies where analysts have a Buy and Hold recommendation.

Fauci Defended NIH Culture Of Secrecy: The $325M Third-Party Royalty Complex... Now We Know The Details - Vimarsana News

Fauci Defended NIH Culture Of Secrecy: The $325M Third-Party Royalty Complex... Now We Know The Details

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero